Abstract
Background
Advanced esophageal dysplasia and early cancers have been treated traditionally with esophagectomy. Endoscopic esophageal mucosectomy (EEM) offers less-invasive therapy, but high-degree stricture formation limits its applicability. We hypothesized that placement of a biodegradable stent (BD-stent) immediately after circumferential EEM would prevent stricturing.
Methods
Ten pigs (five unstented controls, five BD-stent) were utilized. Under anesthesia, a flexible endoscope with a band ligator and snare was used to incise the mucosa approximately 20 cm proximal to the lower esophageal sphincter. A 10-cm, circumferential, mucosal segment was dissected and excised by using snare electrocautery. In the stented group, an 18-×120-mm, self-expanding, woven polydioxanone stent (ELLA-CS, Hradec-Kralove) was deployed. Weekly esophagograms evaluated for percent reduction in esophageal diameter, stricture length, and proximal esophageal dilation. Animals were euthanized when the stricture exceeded 80 % and were unable to gain weight (despite high-calorie liquid diet) or at 14 weeks.
Results
The control group rapidly developed esophageal strictures; no animal survived beyond the third week of evaluation. At 2 weeks post-EEM, the BD-stent group had a significant reduction in esophageal diameter (77.7 vs. 26.6 %, p < 0.001) and degree of proximal dilation (175 vs. 131 %, p = 0.04) compared with controls. Survival in the BD-stent group was significantly longer than in the control group (9.2 vs. 2.4 weeks, p = 0.01). However, all BD-stent animals ultimately developed clinically significant strictures (range, 4–14 weeks). Comparison between the maximum reduction in esophageal diameter and stricture length (immediately before euthanasia) demonstrated no differences between the groups.
Conclusions
Circumferential EEM results in severe stricture formation and clinical deterioration within 3 weeks. BD-stent placement significantly delays the time of clinical deterioration from 2.4 to 9.2 weeks, but does not affect the maximum reduction in esophageal diameter or proximal esophageal dilatation. The timing of stricture formation in the BD-stent group correlated with the loss radial force and stent disintegration.
Similar content being viewed by others
References
Bollschweiler E, Wolfgarten E, Gutschow C, Hölscher AH (2001) Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 92(3):549–555
Brown LM, Devesa SS (2002) Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 11(2):23–56
El-Serag HB, Mason AC, Petersen N, Key CR (2002) Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 50(3):368–372
Rex DK, Cummings OW, Shaw M et al (2003) Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125:1670–1677
Shaheen NJ, Crosby MA, Bozymski EM et al (2000) Is there publication bias in the reporting of cancer risk in Barrett’s esophagus? Gastroenterology 119:333–338
Hage M, Siersema PD, van Dekken H et al (2004) Oesophageal cancer incidence and mortality in patients with long-segment Barrett’s oesophagus after a mean follow-up of 12.7 years. Scand J Gastroenterol 39:1175–1179
Sikkema M, de Jonge PJ, Steyerberg EW et al (2010) Risk of esophageal adenocarcinoma and mortality in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 8:235–244
Sikkema M, Looman CW, Steyerberg EW et al (2011) Predictors for neoplastic progression in patients with Barrett’s esophagus: a prospective cohort study. Am J Gastroenterol 106(7):1231–1238
Prasad GA, Wu TT, Wigle DA et al (2009) Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett’s esophagus. Gastroenterology 137(3):815–823
Swisher SG, Deford L, Merriman KW et al (2000) Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 119(6):1126–1132
van Lanschot JJ, Hulscher JB, Buskens CJ et al (2001) Hospital volume and hospital mortality for esophagectomy. Cancer 91(8):1574–1578
Young MM, Deschamps C, Trastek VF et al (2000) Esophageal reconstruction for benign disease: early morbidity, mortality, and functional results. Ann Thorac Surg 70(5):1651–1655
Santillan AA, Farma JM, Meredith KL et al (2008) Minimally invasive surgery for esophageal cancer. J Natl Compr Canc Netw 6(9):879–884
Sampliner RE (2004) Endoscopic ablative therapy for Barrett’s esophagus: current status. Gastrointest Endosc 59:66–69
Sharma VK, Wang KK, Overholt BF et al (2007) Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett’s esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 65(2):185–195
Fleischer DE, Sharma VK (2008) Endoscopic ablation of Barrett’s esophagus using the halo system. Dig Dis 26(4):280–284
Van Laethem JL, Peny MO, Salmon I et al (2000) Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett’s oesophagus. Gut 46(4):574–577
Vieth M, Ell C, Gossner L et al (2004) Histological analysis of endoscopic resection specimens from 326 patients with Barrett’s esophagus and early neoplasia. Endoscopy 36(9):776–781
Pohl H, Sonnenberg A, Strobel S et al (2009) Endoscopic versus surgical therapy for early cancer in Barrett’s esophagus: a decision analysis. Gastrointest Endosc 70(4):623–631
Pech O, Ell C (2009) Endoscopic therapy of Barrett’s esophagus. Curr Opin Gastroenterol 25(5):405–411
Ell C, May A, Pech O et al (2007) Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest Endosc 65(1):3–10
Esaki M, Matsumoto T, Hirakawa K et al (2007) Risk factors for local recurrence of superficial esophageal cancer after treatment by endoscopic mucosal resection. Endoscopy 39(1):41–45
Hirota WK, Zuckerman MJ, Adler DG et al (2006) ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 63:570–580
Hirasawa K, Kokawa A, Oka H et al (2010) Superficial adenocarcinoma of the esophagogastric junction: long-term results of endoscopic submucosal dissection. Gastrointest Endosc 72(5):960–966
Isomoto H, Yamaguchi N, Nakayama T et al (2011) Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. BMC Gastroenterol 11:46–52
Ono S, Fujishiro M, Niimi K et al (2009) Predictors of postoperative stricture after esophageal endoscopic submucosal dissection for superficial squamous cell neoplasms. Endoscopy 41:661–665
Katada C, Muto M, Manabe T et al (2003) Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions. Gastrointest Endosc 57(2):165–169
Kamler JP, Borsatto R, Binmoeller KF (2002) Circumferential endoscopic mucosal resection in the swine esophagus assisted by a cap attachment. Gastrointest Endosc 55(7):923–928
Ohki T, Yamato M, Murakami D et al (2006) Treatment of oesophageal ulcerations using endoscopic transplantation of tissue engineered autologous oral mucosal epithelial cell sheets in a canine model. Gut 55(12):1704–1710
Rajan E, Gostout C, Feitoza A et al (2005) Widespread endoscopic mucosal resection of the esophagus with strategies for stricture prevention: a preclinical study. Endoscopy 37(11):1111–1115
Willingham FF, Gee DW, Sylla P et al (2009) En bloc esophageal mucosectomy for concentric circumferential mucosal resection (with video). Gastrointest Endosc 69(1):147–151
Sakurai T, Miyazaki S, Miyata G et al (2007) Autologous buccal keratinocyte implantation for the prevention of stenosis after EMR of the esophagus. Gastrointest Endosc 66(1):167–173
Nieponice A, McGrath K, Qureshi I et al (2009) An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR. Gastrointest Endosc 69(2):289–296
AVMA Panel on Euthansia (2001) 2000 Report of the AVMA Panel on Euthansia. J Am Vet Assn 218(5):669–701
Repici A, Vleggaar FP, Hassan C et al (2010) Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study. Gastrointest Endosc 72(5):927–934
Acknowledgments
The stents used in this study were graciously provided by ELLA-CS, Hradec-Kralove, Czech Republic.
Disclosures
Jeffrey M. Marks receives an honorarium as a consultant for Covidien, Olympus, Boston Scientific, WL Gore, and Ethicon and for serving on the advisory board for Apollo Endosurgery. Jeffrey L. Ponsky serves as a consultant for US Endoscopy. None of the other authors have relationships to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pauli, E.M., Schomisch, S.J., Furlan, J.P. et al. Biodegradable esophageal stent placement does not prevent high-grade stricture formation after circumferential mucosal resection in a porcine model. Surg Endosc 26, 3500–3508 (2012). https://doi.org/10.1007/s00464-012-2373-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-012-2373-6